Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study
AbstractThe prevalence of diabetic nephropathy as a cause of end-stage renal disease [ESRD] in Egypt has been examined in small cross-sectional studies, with conflicting results. The need for a large-scale study prompted us to perform this 6-year multiple cross-sectional study. A sample of ESRD patients enrolled in the Egyptian renal data system was evaluated during the period 1996-2001 for the prevalence of diabetic nephropathy. Prevalence gradually increased from 8.9% in 1996, to 14.5% in 2001. The mean age of patients with diabetic nephropathy was significantly higher than that of patients with ESRD from other causes. Mortality was also significantly higher in diabetic patients with ESRD
Afifi, A., El Setouhy, M., El Sharkawy, M., Ali, M., Ahmed, H. et al. (2004). Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study. http://www.who.int/iris/handle/10665/119458
EMHJ - Eastern Mediterranean Health Journal, 10 (4-5), 620-626, 2004
MetadataShow full item record
Showing items related by title and MeSH subject.
Urinary N-acetyl-beta-D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy Abdel Shakour, S.; El Hefnawy, H.; El Yamani, M.Y.; Azmi, Y. (2002)We investigated urinary N-acetyl-beta-D-glucosaminidase [NAG] levels in children with type 1 diabetes as an early marker of tubular damage and studied its correlation with microalbuminuria and glycaemic control. The study group comprised 42 children with type 1 diabetes and 20 healthy children as control. Urinary NAG to urinary creatinine ratio, microalbuminuria, glycated haemoglobin [Hb A1c], blood urea and serum creatinine were estimated. Urinary NAG levels in the children with diabetes were significantly higher than those of controls. There ...
T-cell cytokine production and endothelial dysfunction in type 2 diabetic patients with nephropathy Kamel, L.; Morsy, A.; El Shamaa, A. (2009)This study assessed changes in serum levels of cytokines IFNgamma and IL-10 [biomarkers of inflammatory changes] and soluble biomarkers sICAM-1 and sE-selectin [biomarkers of endothelial dysfunction] in diabetic patients with and without nephropathy. IFNgamma and IL-10 were significantly elevated in patients with diabetic nephropathy [DN] and end-stage renal disease [ESRD] compared with controls and diabetic patients without DN. IFNgamma and IL-10 levels were significantly increased after haemodialysis. sICAM-1 and sE-selectin were significantly ...